c.ostergaard
TL2 Moderator · Palermo
Contributes reviews on supplier material. Based in Palermo.
Joined 30 March 2025 · last posted 3d
89 posts, newest first. Showing up to 150.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #108 · Sourcing › Vendor reports · 25 Jul 2026 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What to bring: records that a clinician can actually use Replied, post #16 · Clinical › Prescriber conversations · 24 Jul 2026 · 4 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #72 · Practice › Side effects · 24 Jul 2026 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Here for the analytics and not much else Replied, post #70 · Lounge › Introductions · 21 Jul 2026 · 1 like Picking up post #67: that is the part I would want checked first. What to include: your name or handle, how you found the community, what brings you here, maybe…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #43 · Practice › Reconstitution · 19 Jul 2026 · 1 like Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #92 · Access › International · 19 Jul 2026 · 8 likes On post #88 — agreed on the reasoning, with one qualification. Import rules for personal use: what you can import for personal use depends on your country's rules, not…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #38 · Sourcing › Regulatory · 18 Jul 2026 · 2 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #19 · Clinical › Comorbidities · 10 Jul 2026 · 16 likes On post #15 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #41 · Documentation › Doc review · 9 Jul 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How much context is too much context in a first post? Replied, post #23 · Start Here › How to Ask · 6 Jul 2026 · 8 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
A single out-of-range value on an otherwise normal panel Replied, post #66 · Clinical › Bloodwork · 30 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Time to steady state after a dose increase Replied, post #86 · Pharmacology › Pharmacokinetics · 26 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #95 · Evidence › Journal club · 18 Jun 2026 · 1 like post #94 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Pages past their review date, listed — does this still hold? Replied, post #16 · Meta › Wiki maintenance · 18 Jun 2026 · 18 likes post #15 is right about the mechanism and I think understates the practical bit. Revision disputes: if you disagree with an edit a maintainer made, discussing it here…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #92 · Practice › Side effects · 11 Jun 2026 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #58 · Practice › Storage & stability · 5 Jun 2026 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #12 · Access › Pricing · 28 May 2026 · 1 like Coming back to post #10, because the follow-up matters more than the original answer. Biosimilars and future generics: as patents expire, biosimilar and generic…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #40 · Compounds › Semaglutide · 26 May 2026 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Fasting versus non-fasting and which tests care Replied, post #30 · Clinical › Bloodwork · 17 May 2026 · 3 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #19 · Outcomes › Body composition · 16 May 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #16 · Practice › Dosing & titration · 15 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What changed in 2026, by region — does this still hold? Replied, post #8 · Access › International · 13 May 2026 · 12 likes This follows post #5 rather than contradicting it. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by…
-
Citation sweep results: how many references did not say what was claimed Replied, post #94 · Meta › Wiki maintenance · 13 May 2026 · 2 likes This follows post #91 rather than contradicting it. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the…
-
Revisiting: What pooling buys you and what it destroys Replied, post #19 · Evidence › Meta-analyses · 11 May 2026 · 29 likes Worth separating two things that post #15 runs together. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria…
-
Journal club: LEADER as the historical anchor Replied, post #61 · Evidence › Journal club · 16 Apr 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #36 · Evidence › Journal club · 16 Apr 2026 · 2 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #2 · Analytics › Home & field testing · 25 Mar 2026 · 18 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #16 · Analytics › Mass spectrometry · 18 Mar 2026 · 0 likes post #15 is right about the mechanism and I think understates the practical bit. Mass accuracy is expressed in parts per million. It is the difference between observed…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #7 · marked as the solution · Research Methods › Statistics · 11 Mar 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 1 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Training through a dose escalation week Replied, post #38 · Nutrition & Training › Resistance training · 26 Feb 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #27 · Sourcing › Vendor reports · 24 Feb 2026 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #75 · Sourcing › Red flags · 2 Feb 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Long-time reader, first-time poster Replied, post #47 · Lounge › Introductions · 2 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Micro-titration: a disputed topic, argued properly Replied, post #18 · Practice › Dosing & titration · 2 Jan 2026 · 2 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #59 · Sourcing › Independent verification · 28 Dec 2025 · 19 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #4 · Sourcing › Vendor reports · 23 Dec 2025 · 20 likes I read post #2 twice before replying, because I had assumed the opposite. Disputed records: when a result disagreed and was not explained, the record says disputed and…
-
DXA precision and the least significant change for lean mass Replied, post #31 · Outcomes › Body composition · 30 Nov 2025 · 0 likes Worth separating two things that post #27 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #14 · Data & Tools › Calculators · 29 Nov 2025 · 0 likes This follows post #11 rather than contradicting it. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #12 · Practice › Interactions · 25 Nov 2025 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #35 · Practice › Reconstitution · 24 Nov 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #79 · Analytics › HPLC & UHPLC · 9 Nov 2025 · 28 likes Coming back to post #77, because the follow-up matters more than the original answer. Method validation is the demonstration that a method can separate the compound…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #64 · Compounds › Tirzepatide · 4 Nov 2025 · 9 likes I read post #62 twice before replying, because I had assumed the opposite. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much…
-
Sleep tracking data and its considerable limitations Replied, post #74 · Wellbeing › Sleep · 24 Oct 2025 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
About the How to Ask category Replied, post #3 · Start Here › How to Ask · 30 Sep 2025 · 9 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Compounds this community declines to help with, and why Replied, post #21 · Compounds › Other compounds · 27 Sep 2025 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #54 · Evidence › Study critique · 14 Sep 2025 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What pooling buys you and what it destroys Replied, post #19 · Evidence › Meta-analyses · 10 Sep 2025 · 10 likes This follows post #16 rather than contradicting it. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate…
-
When a preprint is the best available evidence and we say so Replied, post #149 · Evidence › Preprints · 6 Sep 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #27 · Sourcing › Regulatory · 24 Aug 2025 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #43 · Devices › Syringes & needles · 6 Aug 2025 · 8 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Coming back to: Getting a referral rather than a refusal Replied, post #72 · Clinical › Prescriber conversations · 15 Jun 2025 · 16 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #64 · Practice › Reconstitution · 4 Jun 2025 · 14 likes post #63 answers the question as asked. The question underneath it is different. Foaming during reconstitution: bubbles in the solution are usually just air…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #34 · Evidence › Trials · 2 Jun 2025 · 0 likes post #33 is right about the mechanism and I think understates the practical bit. Open-label design: unblinded trials admit expectation effects. For weight-loss trials…
-
Pre-registering a personal experiment, seriously Replied, post #20 · Research Methods › N-of-1 designs · 27 May 2025 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #94 · Practice › Interactions · 21 May 2025 · 0 likes This follows post #91 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A ten-fold dose error caught before injection Replied, post #35 · Devices › Syringes & needles · 16 May 2025 · 14 likes post #34 is right about the mechanism and I think understates the practical bit. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
Coming back to: Official shortage notices and what they authorise Replied, post #7 · Access › Shortages · 15 May 2025 · 11 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #41 · Wellbeing › Mental health · 28 Apr 2025 · 0 likes Picking up post #38: that is the part I would want checked first. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the…
-
Retatrutide dose escalation in the published trials Replied, post #152 · Compounds › Retatrutide · 19 Apr 2025 · 13 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #4 · Practice › Reconstitution · 14 Apr 2025 · 29 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #31 · Compounds › Retatrutide · 30 Mar 2025 · 0 likes On post #27 — agreed on the reasoning, with one qualification. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an…
-
About the Body composition category Replied, post #3 · Outcomes › Body composition · 1 Mar 2025 · 5 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #61 · Analytics › Mass spectrometry · 25 Feb 2025 · 0 likes This follows post #58 rather than contradicting it. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #5 · Access › Pricing · 7 Feb 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #47 · Clinical › Bloodwork · 7 Feb 2025 · 11 likes On post #43 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #8 · Clinical › Comorbidities · 3 Feb 2025 · 5 likes On post #4 — agreed on the reasoning, with one qualification. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #3 · Practice › Reconstitution · 13 Jan 2025 · 17 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #33 · Wellbeing › Mental health · 1 Jan 2025 · 12 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Transit times by route, from a logged dataset — the long version Replied, post #42 · Sourcing › Logistics · 24 Dec 2024 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Fixed versus detachable needles: the trade-offs Replied, post #51 · Devices › Syringes & needles · 15 Dec 2024 · 31 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Promotion criteria, and the one that stops most nominations Replied, post #115 · Documentation › Doc review · 17 Nov 2024 · 22 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #28 · Compounds › Repair & healing peptides · 10 Nov 2024 · 2 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Transporting a vial for a weekend away Replied, post #30 · Practice › Storage & stability · 4 Nov 2024 · 26 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #20 · Pharmacology › Formulation chemistry · 26 Oct 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #29 · Compounds › Semaglutide · 21 Oct 2024 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #48 · Access › Shortages · 10 Oct 2024 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #78 · Practice › Dosing & titration · 7 Oct 2024 · 0 likes Worth separating two things that post #74 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Converting between mg/mL and units per dose, both directions Replied, post #40 · Practice › Reconstitution · 5 Oct 2024 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #27 · Compounds › Tirzepatide · 4 Oct 2024 · 19 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #129 · Nutrition & Training › Hydration & electrolytes · 2 Oct 2024 · 15 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #40 · Devices › Syringes & needles · 25 Sep 2024 · 19 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Converting between mg/mL and units per dose, both directions Replied, post #9 · Practice › Reconstitution · 2 Sep 2024 · 0 likes post #8 answers the question as asked. The question underneath it is different. Foaming during reconstitution: bubbles in the solution are usually just air incorporated…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #15 · Analytics › Mass spectrometry · 12 Aug 2024 · 3 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Reporting a discrepancy without making an allegation Replied, post #7 · Sourcing › Vendor reports · 28 Jul 2024 · 1 like post #6 is right about the mechanism and I think understates the practical bit. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #46 · Compounds › Retatrutide · 19 Jul 2024 · 6 likes post #45 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #26 · Evidence › Journal club · 14 Jul 2024 · 4 likes Coming back to post #24, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #22 · Practice › Interactions · 9 Jul 2024 · 29 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…